AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

FGFR1 inhibition by carvacrol: A novel strategy for oral squamous cell carcinoma therapy

Shuzhen Xianga,1, Hongyan Zhangb,1, Qian Wanga, Jiajia Fana, Shiheng Jiac,d, Lan Zhanga, Wei Mae, Minda Liua( ), Yanshu Lib( ), Wei Daia( )
Department of Oral Maxillofacial-Head and Neck Surgery, School of Stomatology, China Medical University, Oral Diseases Laboratory of Liaoning, Shenyang, Liaoning 110000, China
Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, Liaoning 110122, China
Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China
Key Laboratory of Molecular Pathology and Epidemiology of Gastric Cancer in the Universities of Liaoning Province, Shenyang, Liaoning 110001, China
School of Stomatology, China Medical University, Shenyang, Liaoning 110122, China

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).

1 These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 12 Issue 5,
September 2025
Article number: 101479
DOI: 10.1016/j.gendis.2024.101479

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Xiang S, Zhang H, Wang Q, et al. FGFR1 inhibition by carvacrol: A novel strategy for oral squamous cell carcinoma therapy. Genes & Diseases, 2025, 12(5): 101479. https://doi.org/10.1016/j.gendis.2024.101479

466

Views

1

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD
Received: 31 July 2024
Published: 04 December 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).